Jan 18, 2024   SOURCE: PR NewsWire

Global Dog Vaccines Market Size/Share Envisaged to Reach USD 2,708.28 Million By 2032, at 5.7% CAGR: Research by Polaris Market Research

NEW YORK, Jan. 18, 2024 /PRNewswire/ -- A latest research report [115+] pages with 360-Degree visibility, titled "Dog Vaccine Market Share, Size, Trends, Industry Analysis Report, By Vaccine Type, By Disease Type, By Route of Administration, By Duration of Immunity, By Component, By Region, And Segment Forecasts, 2024 - 2032" published by Polaris Market Research in its research repository.

https://mma.prnewswire.com/media/1316207/4467633/Polaris_Market_Research_Logo.jpg

The global dog vaccine market size & share is predicted to grow from USD 1,644.45 million in 2023 to USD 2,708.28 million in 2032. It is anticipated to grow at a Compound Annual Growth Rate (CAGR) of 5.7% from 2023 to 2032, according to the latest report by Polaris Market Research.

How Big is Dog Vaccines Market Size & Share?

    --  A Quick Review

Vaccines assist arrange a dog's immune system to fortify itself from any takeover of disease generating organisms. Vaccines comprise antigens that impersonate disease-generating organisms in a dog's immune system but do not literally cause disease. The rapidly rising demand for dog vaccine market can be attributed to the reason of puppy and dog vaccines is to gently revive the immune system by possessing it identify the antigens existence. In this manner, if a dog becomes prone to the actual disease, its immune system will identify it and thus be arranged to battle it or, at the most, decrease its impact.

The dog vaccine market growth can be attributed to the escalating current of pet possession and the escalating circumstance of pet humanization. This trend highlights curing pets as inherent representatives of the family causing a larger concentration on their welfare and solace. As described by My Golden Retriever Puppies in August 2023, dogs and cats project out as the dearest and broadly embraced pets worldwide, with the US solely bragging roughly 89.7 million pet dogs.

Request Free Sample Copy of Dog Vaccines Market Research Report @ https://www.polarismarketresearch.com/industry-analysis/dog-vaccine-market/request-for-sample

Purchase a Full Detail Report With Complete TOC HERE

(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, Table of Contents, Graphical introduction of regional analysis, Top players in the market with their revenue analysis and our research methodology.)

Which are the Largest Dog Vaccine Players in the World?

    --  Bioveta a.s
    --  Hester Biosciences Limited
    --  Boehringer Ingelheim International GmbH
    --  Brilliant Bio Pharma
    --  Heska Corporation
    --  Merck & Co., Inc.
    --  Virbac
    --  Zendal Group
    --  Elanco
    --  Zoetis Services

Request for PDF Brochure of This Report: https://www.polarismarketresearch.com/industry-analysis/dog-vaccine-market/request-for-sample

Important Highlights from the Report

    --  The reason for puppy and dog vaccines is to gently revive the immune
        system by possessing it to identify the antigen's existence, which will
        push the market exponentially.
    --  The escalating current of pet possession and the growing circumstance of
        pet humanization are causing the market to grow.
    --  The dog vaccine market segmentation is primarily based on vaccine type,
        disease type, duration of immunity, route of administration, and region.
    --  North America has dominated the market with the largest share in 2023

Market's Prime Determinants of Growth, Trends, and Opportunities

    --  Growing pet acquisition: One of the foremost propellers behind this
        evolution is the growing estimate of pet acquisition globally. The dog
        vaccine market size is expanding as more people acquire dogs, and there
        is a correlating escalation in demand for precautionary healthcare
        estimates involving vaccinations. Pet owners are becoming more conscious
        of the graveness of vaccines in defending the health and comfort of
        their furry partners, which is pushing the market ahead.
    --  Existence of contagious illnesses: The escalating pervasiveness of
        contagious illnesses amongst dogs has highlighted the prerequisite of
        vaccination as an important inhibitory approach. The dog vaccine market
        sales are soaring as illnesses such as parvovirus, distemper, and rabies
        create notable ultimatum to canine dwellers rendering vaccination an
        important facet of accountable pet possession. Veterinary experts and
        animal health bodies have been influential in advancing the
        noteworthiness of systematic vaccination additionally pushing market
        growth.

Trends and Opportunities

Vaccine advancements: The making of successful bivalent viral vector-dependent vaccines earmarking both rabies and canine distemper bears assurance for regulating both illnesses with solitary vaccine contenders, especially in advancing countries. Further, in the times to come, vaccine advancement endeavors should categorize the formation of a multivalent vaccine providing a wide gamut safeguarding fruitfulness circumscribing other representatives of the Lyssavirus. This perspective could be highly successful in attenuating this mortal illness. Additionally, a survey of rabies vaccines engaging small interfering RNA (siRNA) is an organic organizer, or the advancement of bi-specific antibody (BsAb) dependent cure for the rabies virus dispenses more encouraging alternatives in the remedial facets of rabies.

Segmental Analysis

    --  Attenuated Live Segment Witnessed a Steep Surge

Based on the vaccine, the attenuated live segment witnessed a steep surge. The dog vaccine market demand is on the rise as this is basically because of the effectiveness of attenuated live vaccines in offering to safeguard against illnesses and contamination, providing endless resistance. Particularly vaccines for canine adenovirus-2 and parvoviruses involving canine adenovirus type 2 (CAV-2) penetrate into the grouping of attenuated live vaccines. Particularly, the CAV-2 vaccine plays an important part in defending against contagious hepatitis.

    --  Canine Infectious Respiratory Disease Complex (CIRDC) Segment Dominated
        the Market

Based on disease, the canine infectious respiratory disease complex (CIRDC) segment dominated the market. The dog vaccine market trends include the existence of several productive proxies for the CIRDC, encouraging the continual advancement of contemporary vaccines. The intricate creation of CIRDC, including countless pathogens such as bacteria and viruses, demands varied vaccine expressions to tackle the scale of contagious agents causing respiratory illnesses in dogs.

Inquire more about this report before purchase @ https://www.polarismarketresearch.com/industry-analysis/dog-vaccine-market/inquire-before-buying

(Inquire a report quote OR available discount offers to the sales team before purchase.)

Dog Vaccines Market: Reports Scope



     
     Report Attribute          
     
              Details


        Revenue forecast in 2032  
     USD 2,708.28 Million


        Market size value in 2024 
     USD 1,736.21 Million



     
     Expected CAGR Growth      
     5.7% from 2023 - 2032



     
     Base Year                                                                                                                             2023



     
     Forecast Year             
     2024 - 2032



     
     Top Market Players          Bioveta, Hester Biosciences, Boehringer Ingelheim, Brilliant Bio Pharma, Heska Corp., Merck, Virbac,
                                     Elanco, and Zoetis Services



     
     Segments Covered          
     By Material, Product Type, By Straw Length, Diameter, Sales Channel, End Use, By Region



     
     Customization Options                  Customized purchase options are available to meet any research needs. 
              Explore customized
                                                purchase options

Regional Insights

North America: This region held the largest dog vaccine market share due to escalating consciousness of prohibitive healthcare for pets and the escalating ratio of pet freehold are notable benefactors to market growth. A noteworthy instance is the combined endeavors of Merck, Petco Love, and an NGO, which culminated in the dispensation of 1 million unlimited pet vaccines by encompassing October 2022.

Asia Pacific: This region is forecast to grow at a speedy pace due to the expected advancement in income measures, altering demographics, and enhancements in the quality of life are confident to push market augmentation in this geographical domain. As declared by CNBC in October 2022, India is anticipated to observe a notable escalation of 4.6% in actual remuneration, while China is predicted to encounter a growth of 3.6%. This escalation in income standards is probable to restore escalated disbursement on pets.

Browse the Detail Report "Dog Vaccine Market Share, Size, Trends, Industry Analysis Report, By Vaccine Type, By Disease Type, By Route of Administration, By Duration of Immunity, By Component, By Region, And Segment Forecasts, 2024 - 2032" with in-depth TOC: https://www.polarismarketresearch.com/industry-analysis/dog-vaccine-market

For Additional Information OR Media Enquiry, Please Mail At: sales@polarismarketresearch.com

Key Questions Answered in the Report

    --  What is the current and expected dog vaccine market value?Ans: The
        current market value is USD 1,736.21 million, and the expected market
        value is USD 2,708.28 million.



    --  At what CAGR is the market expected to grow during the forecast
        period?Ans: The CAGR at which the market is expected to grow is 5.7%.



    --  Which factors are driving the market growth?Ans: The factors driving the
        market growth are growing pet acquisition and the existence of
        contagious illnesses.

    --  Which segment accounts for the largest dog vaccine market share?Ans: The
        attenuated live segment accounts for the largest market share.

Polaris Market Research has segmented the dog vaccine market report based on vaccine type, disease type, duration of immunity, and region:

Dog Vaccine, Vaccine Type Outlook (Revenue - USD Million, 2019 - 2032)

    --  Modified/ Attenuated Live
    --  Inactivated (Killed)
    --  Others

Dog Vaccine, Disease Type Outlook (Revenue - USD Million, 2019 - 2032)

    --  Canine Distemper
    --  Canine Infectious Respiratory Disease Complex (CIRDC)
    --  Canine Parvovirosis/ Parvovirus Disease
    --  Canine Leptospirosis
    --  Canine Lyme Disease
    --  Infectious Canine Hepatitis
    --  Canine Rabies
    --  Others

Dog Vaccine, Duration of Immunity Outlook (Revenue - USD Million, 2019 - 2032)

    --  1-Year
    --  3-Year
    --  Others

Dog Vaccine, Regional Outlook (Revenue - USD Million, 2019 - 2032)

    --  North America
        --  U.S.
        --  Canada
    --  Europe
        --  Germany
        --  UK
        --  France
        --  Italy
        --  Spain
        --  Russia
        --  Netherlands
    --  Asia Pacific
        --  China
        --  India
        --  Japan
        --  South Korea
        --  Indonesia
        --  Malaysia
    --  Latin America
        --  Argentina
        --  Brazil
        --  Mexico
    --  Middle East & Africa
        --  UAE
        --  Saudi Arabia
        --  Israel
        --  South Africa

Browse More Research Reports:

    --  Engine Bearings Market Size & Share Report, 2024-2032:
        https://www.polarismarketresearch.com/industry-analysis/engine-bearings-
        market
    --  Sugar Substitutes Market Size & Share Report, 2024-2032:
        https://www.polarismarketresearch.com/industry-analysis/sugar-substitute
        s-market
    --  Automotive Brake System Market Size & Share Report, 2024-2032:
        https://www.polarismarketresearch.com/industry-analysis/automotive-brake
        -system-market
    --  Radiation Dose Management Market Size & Share Report, 2024-2032:
        https://www.polarismarketresearch.com/industry-analysis/radiation-dose-m
        anagement-market
    --  Latin America Industrial Pumps Market Size & Share Report, 2024-2032:
        https://www.polarismarketresearch.com/industry-analysis/latin-america-in
        dustrial-pumps-market

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

Contact:

Likhil G
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | twitter
Blog: https://polarismarketresearch.medium.com

Logo: https://mma.prnewswire.com/media/1316207/4467633/Polaris_Market_Research_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/global-dog-vaccines-market-sizeshare-envisaged-to-reach-usd-2-708-28-million-by-2032--at-5-7-cagr-research-by-polaris-market-research-302038408.html

SOURCE Polaris Market Research